Search

everythinglearnresearchcommunity

for

Search:↓

Some medications can help increase sexual desire and function in women.

Testosterone therapy can help postmenopausal women with low sexual desire but needs more safety research and should be used with estrogen therapy.

A new microneedle patch and yellow light therapy significantly promote hair regrowth.

Both mouse and rat models are effective for testing alopecia areata treatments.

Hair analysis for stress and reproductive hormones in wildlife needs more research for accuracy across species.

The current system can't fully test all combination treatments, so alternative methods and regulatory flexibility are needed.

The conclusion is that a new test was created to find substances that affect specific ion channels, and it works well for drug discovery.

Advanced human skin models improve drug development and could replace animal testing.

Adults with persistent scalp issues unresponsive to typical treatments should be tested for the fungal infection tinea capitis to start the right antifungal medication.

Doctors should diagnose hair loss by examining the patient and possibly doing tests, and then treat it based on the type, which may prevent permanent hair loss.

Bimatoprost is promising for treating some types of hair loss but needs more testing for androgenetic alopecia.

Products should be called 'sperm-safe' only after thorough, well-designed tests.

Treat scalp and beard fungal infections early with oral antifungal medication and sometimes topical therapy, avoiding unnecessary allergy tests and surgery.

Many treatments for hair loss show potential, but more testing is needed to confirm their effectiveness. Only minoxidil for women and minoxidil and finasteride for men are FDA approved.

Eczema patients have a lower skin lipid to protein ratio, older and longer-staying hospital patients are more likely to get pressure ulcers, hair loss in AGA is linked to muscle degeneration, vitamin D deficiency is common in alopecia areata and linked to its severity, standard liver tests don't effectively detect fibrosis in psoriasis patients on methotrexate, and bullous pemphigoid patients have a higher death risk but combination therapy may reduce it.

A 45-year-old woman with autoimmune diseases experienced patchy hair loss due to alopecia areata, which has no cure but can be treated, with varying success.

Dr. Vera H. Price's 1979 work emphasizes the importance of accurate diagnosis and personalized treatment for hair loss.

Most hair loss disorders can be accurately diagnosed and treated in an outpatient setting.

The author clarified that Alopecia Areata Incognita (AAI) and diffuse Alopecia Areata (AA) are different conditions and the case discussed was actually AA, not AAI.

Mouse hair follicle stem cells were successfully isolated and used to regenerate hair follicles with two different methods.

A woman got severe scalp burns from a salon's improper hair bleaching treatment.

Hormone treatments in transsexual individuals reduce hair growth and oil production in male-to-females and increase them in female-to-males.

Hormone therapy is essential for transgender individuals but requires careful management due to possible metabolic effects.

The conclusion is that managing androgen excess requires long-term treatment, including hormonal contraceptives and androgen blockers, with follow-up after six months.

Testosterone replacement can help women with low libido and mood, but they need to have enough estrogen first to avoid side effects.

Hormone treatment for transgender patients may not need to be stopped before surgery, but more research is needed, especially on estrogen.

Different types of hair loss in lupus need careful diagnosis for proper treatment.

Hair loss in lupus is different from hair loss in alopecia areata and may indicate lupus activity.

Alopecia areata is an autoimmune hair loss condition treated with corticosteroids, and histologic confirmation is the best diagnosis method.

Topical minoxidil successfully treated temporal triangular alopecia.